Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Skyline Medical Inc    

SKYLINE MEDICAL INC
Mes dernières consult.
Most popular
  Report  
SummaryChartsNewsCalendarCompany 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles

Skyline Medical to Hold Business Update Conference Call on November 15, 2017

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/10/2017 | 11:01pm CEST

MINNEAPOLIS, Nov. 10, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or the “Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announced today that management will hold a conference call on November 15, 2017  to provide a business update and host a discussion on recent and upcoming milestones.

The conference call is scheduled to begin at 11:00 a.m. (Eastern Time). A webcast of the event will be available on the Investors section of the Company’s website at www.skylinemedical.com.

To access the conference call, U.S.-based listeners should dial (844) 295-1034 and international listeners should dial (574) 990-1037. All listeners should provide the following passcode: 9496546

About Skyline Medical

Skyline Medical produces a fully automated, patented, FDA-cleared waste fluid disposal system that virtually eliminates staff exposure to blood, irrigation fluid and other potentially infectious fluids found in the healthcare environment. Antiquated manual fluid handling methods that require hand carrying and emptying filled fluid canisters present an exposure risk and potential liability. Skyline Medical's STREAMWAY System fully automates the collection, measurement and disposal of waste fluids and is designed to: 1) reduce overhead costs to hospitals and surgical centers; 2) improve compliance with OSHA and other regulatory agency safety guidelines; 3) improve efficiency in the operating room, and radiology and endoscopy departments, thereby leading to greater profitability; and 4) provide greater environmental stewardship by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills each year in the U.S.  For additional information, please visit www.skylinemedical.com.

Contacts:

Skyline Medical
Carl Schwartz, Chief Executive Officer
(651) 389-4800
[email protected]

Investors
KCSA Strategic Communications
Elizabeth Barker
(212) 896-1203
[email protected]

 


© GlobeNewswire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SKYLINE MEDICAL INC
06/21PRECISION THERAPEUTICS : Projects Meaningful Streamway System Sales in Europe in..
AQ
05/31Precision Therapeutics Launches New Website
GL
05/17PRECISION THERAPEUTICS : Stock-Sector Releases Interview with CEO of Helomics Di..
AQ
05/15PRECISION THERAPEUTICS : Management's Discussion and Analysis of Financial Condi..
AQ
05/15Precision Therapeutics Reports First Quarter 2018 Financial Results
GL
05/11PRECISION THERAPEUTICS : Projects Meaningful STREAMWAY System Sales in Europe in..
AQ
05/10Precision Therapeutics Projects Meaningful STREAMWAY System Sales in Europe i..
GL
05/08PRECISION THERAPEUTICS : to Hold Business Update Conference Call on May 15, 2018
AQ
04/26PRECISION THERAPEUTICS INC. : Changes in Registrant's Certifying Accountant, Fin..
AQ
04/24PRECISION THERAPEUTICS : Signs Letter of Intent to Purchase Remainder of Helomic..
AQ
More news
News from SeekingAlpha
02/01Skyline down 3% on profit-taking 
02/01PREMARKET LOSERS AS OF 9 : 05 am (2/1/2018) 
01/25Skyline Medical to change name to Precision Therapeutics February 1 
01/05Skyline Medical prices equity offering at $0.95/Unit; shares down 6% 
2017HEALTHCARE - TOP 5 GAINERS / LOSERS : 00 am 
Chart SKYLINE MEDICAL INC
Duration : Period :
Skyline Medical Inc Technical Analysis Chart | US83084T6064 | 4-Traders
Managers
NameTitle
Carl Schwartz President, Chief Executive Officer & Director
Thomas J. McGoldrick Chairman
David O. Johnson Chief Operating Officer
Robert L. Myers CFO, Secretary & Principal Accounting Officer
Andrew P. Reding Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
SKYLINE MEDICAL INC14.85%0
THERMO FISHER SCIENTIFIC9.94%83 985
DANAHER CORPORATION6.98%69 368
INTUITIVE SURGICAL32.41%54 745
BOSTON SCIENTIFIC CORPORATION31.59%45 009
ILLUMINA29.37%41 550